| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.03.23 | Sequana Medical - CHIHUAHUA results clear path to MOJAVE | 328 | Edison Investment Research | Sequana Medical reported positive results from the CHIHUAHUA Phase I study of its second-generation DSR (direct sodium removal) product, DSR 2.0. This clears a key hurdle needed before filing a US Investigational... ► Artikel lesen | |
| 01.03.23 | Notice - Termination of coverage - Termination of coverage | 216 | Edison Investment Research | Edison Investment Research is terminating coverage on Doctor Care Anywhere (DOC), Argentex Group (AGFX), Newmont Corporation (NEM), GB Group (GBG), Abliva (ABLI) and TIE Kinetix (TIE). Please note you... ► Artikel lesen | |
| 01.03.23 | Pan American Silver - FY22 results beat consensus expectations | 820 | Edison Investment Research | Pan American Silver (PAAS) reported an encouraging set of Q4/FY22 results, with Q4 EBITDA of US$92.3m exceeding consensus expectations by c 21% and FY22 EBITDA coming in at US$272m, c 6% above consensus.... ► Artikel lesen | |
| 01.03.23 | MotorK - Cash-generative strategy in place | 424 | Edison Investment Research | MotorK's FY22 results showed a 40% y-o-y increase in reported revenue and a 78% increase in annual recurring revenue (ARR, 40% organic growth), driven by new enterprise contract wins, higher retail... ► Artikel lesen | |
| 01.03.23 | Borussia Dortmund - FIFA World Cup affects Bundesliga schedule | 465 | Edison Investment Research | Borussia Dortmund's Q223 results reflect the negative effects of the first time staging of the FIFA World Cup during the football season, offset by underlying improvements due to the absence of COVID-19-related... ► Artikel lesen | |
| 01.03.23 | OSE Immunotherapeutics - Encouraging safety data for OSE-127 | 372 | Edison Investment Research | OSE Immunotherapeutics has announced that the data from its earlier Phase I study for OSE-127/S95011, initially released in 2019, has been published in the Journal of Immunology. The study, involving... ► Artikel lesen | |
| 01.03.23 | Incannex Healthcare - Strong cash position supports clinical progression | 293 | Edison Investment Research | Following its Q223 cash flow report in February, Incannex has reported detailed interim H123 results. The period was mainly focused on enhanced clinical efforts across its drug development portfolio... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 329 |
| EVOTEC | 295 |
| TUI | 210 |
| NVIDIA | 179 |
| DEUTSCHE BANK | 172 |
| BAYER | 158 |
| PLUG POWER | 145 |
| NEL | 135 |
| RHEINMETALL | 133 |
| SIEMENS ENERGY | 112 |
| BARRICK GOLD | 111 |
| COMMERZBANK | 107 |
| BASF | 104 |
| TESLA | 104 |
| RWE | 93 |
| VOLKSWAGEN | 93 |
| BYD | 87 |
| ALLIANZ | 85 |
| DEUTSCHE LUFTHANSA | 85 |
| MERCEDES-BENZ | 79 |
| RENK GROUP | 79 |
| DEUTSCHE TELEKOM | 76 |
| HEIDELBERGER DRUCK | 76 |
| ALIBABA | 72 |
| AIXTRON SE | 71 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
